Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Non-Current Assets: 2014-2024

Historic Non-Current Assets for Viking Therapeutics (VKTX) over the last 11 years, with Dec 2024 value amounting to $1.1 million.

  • Viking Therapeutics' Non-Current Assets fell 42.53% to $712,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $712,000, marking a year-over-year decrease of 42.53%. This contributed to the annual value of $1.1 million for FY2024, which is 12.65% down from last year.
  • Per Viking Therapeutics' latest filing, its Non-Current Assets stood at $1.1 million for FY2024, which was down 12.65% from $1.3 million recorded in FY2023.
  • In the past 5 years, Viking Therapeutics' Non-Current Assets ranged from a high of $1.5 million in FY2022 and a low of $134,000 during FY2021.
  • Moreover, its 3-year median value for Non-Current Assets was $1.3 million (2023), whereas its average is $1.3 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first plummeted by 66.33% in 2021, then spiked by 1,011.19% in 2022.
  • Yearly analysis of 5 years shows Viking Therapeutics' Non-Current Assets stood at $398,000 in 2020, then slumped by 66.33% to $134,000 in 2021, then spiked by 1,011.19% to $1.5 million in 2022, then declined by 15.04% to $1.3 million in 2023, then declined by 12.65% to $1.1 million in 2024.